Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen R Bloom

Showing results (211-220 of 252) with videos related to

Pageof 26
Sort By:
Brain Structure & Function|March 12, 2015
Kisspeptin signaling in the amygdala modulates reproductive hormone secretionAlexander N Comninos, Jelena Anastasovska, Meliz Sahuri-Arisoylu, et al.
The Journal of Clinical Endocrinology and Metabolism|August 22, 2014
Combination of peptide YY3-36 with GLP-1(7-36) amide causes an increase in first-phase insulin secretion after IV glucoseTricia M Tan, Victoria Salem, Rachel C Troke, et al.
ACS Pharmacology & Translational Science|April 17, 2020
The Influence of Peptide Context on Signaling and Trafficking of Glucagon-like Peptide-1 Receptor Biased AgonistsZijian Fang, Shiqian Chen, Philip Pickford, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 11, 2024
Chronic treatment with glucagon-like peptide-1 and glucagon receptor co-agonist causes weight loss-independent improvements in hepatic steatosis in mice with diet-induced obesityEmma Rose McGlone, David C D Hope, Iona Davies, et al.
The Journal of Clinical Endocrinology and Metabolism|February 13, 2014
Increasing LH pulsatility in women with hypothalamic amenorrhoea using intravenous infusion of Kisspeptin-54Channa N Jayasena, Ali Abbara, Johannes D Veldhuis, et al.
British Journal of Clinical Pharmacology|August 13, 2011
Pharmacokinetics, adverse effects and tolerability of a novel analogue of human pancreatic polypeptide, PP 1420Tricia M Tan, Benjamin C T Field, James S Minnion, et al.
Endocrinology|September 10, 2005
Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additivelyNicola M Neary, Caroline J Small, Maralyn R Druce, et al.
Clinical Chemistry|March 30, 2010
Identification of the hormone kisspeptin in amniotic fluidGurjinder M K Nijher, Jordan E Baxter, Owais B Chaudhri, et al.
Scientific Reports|February 17, 2015
Neurokinin B administration induces hot flushes in womenChanna N Jayasena, Alexander N Comninos, Evgenia Stefanopoulou, et al.
The Journal of Biological Chemistry|December 3, 2020
Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signaling at glucagon family receptorsBen Jones, Emma Rose McGlone, Zijian Fang, et al.
Pageof 26

Showing results (211-220 of 252) with videos related to

Sort By:
Pageof 26
Brain Structure & Function|March 12, 2015
Kisspeptin signaling in the amygdala modulates reproductive hormone secretionAlexander N Comninos, Jelena Anastasovska, Meliz Sahuri-Arisoylu, et al.
The Journal of Clinical Endocrinology and Metabolism|August 22, 2014
Combination of peptide YY3-36 with GLP-1(7-36) amide causes an increase in first-phase insulin secretion after IV glucoseTricia M Tan, Victoria Salem, Rachel C Troke, et al.
ACS Pharmacology & Translational Science|April 17, 2020
The Influence of Peptide Context on Signaling and Trafficking of Glucagon-like Peptide-1 Receptor Biased AgonistsZijian Fang, Shiqian Chen, Philip Pickford, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 11, 2024
Chronic treatment with glucagon-like peptide-1 and glucagon receptor co-agonist causes weight loss-independent improvements in hepatic steatosis in mice with diet-induced obesityEmma Rose McGlone, David C D Hope, Iona Davies, et al.
The Journal of Clinical Endocrinology and Metabolism|February 13, 2014
Increasing LH pulsatility in women with hypothalamic amenorrhoea using intravenous infusion of Kisspeptin-54Channa N Jayasena, Ali Abbara, Johannes D Veldhuis, et al.
British Journal of Clinical Pharmacology|August 13, 2011
Pharmacokinetics, adverse effects and tolerability of a novel analogue of human pancreatic polypeptide, PP 1420Tricia M Tan, Benjamin C T Field, James S Minnion, et al.
Endocrinology|September 10, 2005
Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additivelyNicola M Neary, Caroline J Small, Maralyn R Druce, et al.
Clinical Chemistry|March 30, 2010
Identification of the hormone kisspeptin in amniotic fluidGurjinder M K Nijher, Jordan E Baxter, Owais B Chaudhri, et al.
Scientific Reports|February 17, 2015
Neurokinin B administration induces hot flushes in womenChanna N Jayasena, Alexander N Comninos, Evgenia Stefanopoulou, et al.
The Journal of Biological Chemistry|December 3, 2020
Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signaling at glucagon family receptorsBen Jones, Emma Rose McGlone, Zijian Fang, et al.
Pageof 26